230 related articles for article (PubMed ID: 31924380)
21. Relieving the pruritus of atopic dermatitis: a meta-analysis.
Sher LG; Chang J; Patel IB; Balkrishnan R; Fleischer AB
Acta Derm Venereol; 2012 Sep; 92(5):455-61. PubMed ID: 22773026
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
[TBL] [Abstract][Full Text] [Related]
23. Itch in Atopic Dermatitis.
Kido-Nakahara M; Furue M; Ulzii D; Nakahara T
Immunol Allergy Clin North Am; 2017 Feb; 37(1):113-122. PubMed ID: 27886901
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis.
Nakashima C; Otsuka A; Kabashima K
Exp Dermatol; 2018 Apr; 27(4):327-331. PubMed ID: 29524262
[TBL] [Abstract][Full Text] [Related]
25. Gamisasangja-tang suppresses pruritus and atopic skin inflammation in the NC/Nga murine model of atopic dermatitis.
Park BK; Park YC; Jung IC; Kim SH; Choi JJ; Do M; Kim SY; Jin M
J Ethnopharmacol; 2015 May; 165():54-60. PubMed ID: 25721805
[TBL] [Abstract][Full Text] [Related]
26. Chronically relapsing pruritic dermatitis in the rats treated as neonate with capsaicin; a potential rat model of human atopic dermatitis.
Back SK; Jeong KY; Li C; Lee J; Lee SB; Na HS
J Dermatol Sci; 2012 Aug; 67(2):111-9. PubMed ID: 22721998
[TBL] [Abstract][Full Text] [Related]
27. Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream.
Zirwas MJ; Barkovic S
J Drugs Dermatol; 2017 Mar; 16(3):243-247. PubMed ID: 28301620
[TBL] [Abstract][Full Text] [Related]
28. Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema.
Groene D; Martus P; Heyer G
Exp Dermatol; 2001 Apr; 10(2):110-7. PubMed ID: 11260249
[TBL] [Abstract][Full Text] [Related]
29. Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo.
Vu M; Heyes C; Robertson SJ; Varigos GA; Ross G
Clin Exp Dermatol; 2017 Dec; 42(8):942-944. PubMed ID: 29034491
[No Abstract] [Full Text] [Related]
30. Recent Therapeutic Advances in Pruritus Management for Atopic Dermatitis Patients: A Welcome Addition of Asivatrep to Our Arsenal of Future Topical Treatments.
Bartolucci S; Netchiporouk E; Litvinov IV
J Cutan Med Surg; 2019; 23(5):551-552. PubMed ID: 31478771
[No Abstract] [Full Text] [Related]
31. Efficacy of tofacitinib in Kimura's disease in a patient with concomitant atopic dermatitis.
Sun Q; Fu B; Li S; Fang H; Qiao J
Clin Exp Dermatol; 2021 Oct; 46(7):1336-1338. PubMed ID: 33837590
[No Abstract] [Full Text] [Related]
32. Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis.
Scuron MD; Fay BL; Connell AJ; Peel MT; Smith PA
Front Immunol; 2020; 11():620098. PubMed ID: 33658996
[TBL] [Abstract][Full Text] [Related]
33. Synergetic effects of prednisolone and olopatadine on atopic dermatitis model of hairless mice.
Kagawa Y; Izawa K; Yano H; Kamei C
Pharmacology; 2010; 85(5):286-94. PubMed ID: 20453552
[TBL] [Abstract][Full Text] [Related]
34. Does mechanical scratching cause the recruitment of T-helper 17 cells in atopic dermatitis?
Furue K; Ito T; Tsuji G; Esaki H; Kido-Nakahara M; Nakahara T; Furue M
J Dermatol; 2019 Nov; 46(11):e436-e437. PubMed ID: 31294475
[No Abstract] [Full Text] [Related]
35. Antihistamines and their role as antipruritics.
O'Donoghue M; Tharp MD
Dermatol Ther; 2005; 18(4):333-40. PubMed ID: 16297006
[TBL] [Abstract][Full Text] [Related]
36. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
[TBL] [Abstract][Full Text] [Related]
37. Drugs on the Horizon for Chronic Pruritus.
McEwen MW; Fite EM; Yosipovitch G; Patel T
Dermatol Clin; 2018 Jul; 36(3):335-344. PubMed ID: 29929605
[TBL] [Abstract][Full Text] [Related]
38. Two cases of vitiligo vulgaris treated with topical Janus kinase inhibitor delgocitinib.
Yagi K; Ishida Y; Otsuka A; Kabashima K
Australas J Dermatol; 2021 Aug; 62(3):433-434. PubMed ID: 33667323
[No Abstract] [Full Text] [Related]
39. In the management of mild to moderate atopic dermatitis in adults.
Recchia M
J Drugs Dermatol; 2007 Mar; 6(3):252; author reply 252. PubMed ID: 17373186
[No Abstract] [Full Text] [Related]
40. Topical Application of ASN008, a Permanently Charged Sodium Channel Blocker, Shows Robust Efficacy, a Rapid Onset, and Long Duration of Action in a Mouse Model of Pruritus.
Ramachandran R; Thompson SK; Malkmus S; Mieda T; Lin JH; Gupta S; Yaksh TL
J Pharmacol Exp Ther; 2020 Sep; 374(3):521-528. PubMed ID: 32616515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
